On Cancer

and/or

68 Blog posts found

In the Clinic

What Is Metastatic Cancer? Answers to Six Common Questions

Learn about MSK’s approach to treating cancer that has spread from the original tumor to other parts of the body.

A color image of a liver with metastatic tumors

Finding

Why Do Some People Beat the Odds against Pancreatic Cancer?

Scientists think they now understand why some people with pancreatic cancer survive for many years. Hint: It involves the immune system.

An illustration of the human pancreas

In the Lab

Why Do Immune Checkpoint Inhibitors Work for Only Some People with Cancer?

Learn about why checkpoint inhibitors, a class of immunotherapy drugs, 
is paying off — but only for some patients.

MSK physician­scientist Luis Diaz

Announcement

FDA Approves CAR T Cell Therapy for Non-Hodgkin Lymphoma

This is the second regulatory approval of the cell-based immunotherapy for a blood cancer.

Medical oncologist Anas Younes

Announcement

FDA Approves First CAR T Cell Therapy for Leukemia

Children, teens, and young adults with leukemia that have stopped responding to chemotherapy are the first eligible to receive the new treatment.

Pediatric oncologist Kevin Curran with CAR T patient Esmeralda Pineda

Perspective

MSK’s Vision to Transform Lymphoma Treatment

Anas Younes, Chief of the Lymphoma Service, details MSK’s ambitious strategy for advancing lymphoma therapies.

Anas Younes, Chief of the Lymphoma Service at MSK

In the Clinic

The Science Behind the FDA’s Approval of an Immunotherapy for Mismatch Repair–Deficient Cancers

A new paper from MSK physician-scientist Luis Diaz presents the evidence on which the FDA approved the immunotherapy drug pembrolizumab for cancers with a specific genetic abnormality.

MSK medical oncologist Luis Diaz, Jr.

In the News

#ASCO17: Post-Conference Roundup of Themes and Trends

Read up on the progress being made in several key areas of cancer research, including immunotherapy, targeted therapy, precision surgery, and epigenetics.

American Society of Clinical Oncology logo

Q&A

Q & A: MSK Leads the Way in Treating Head and Neck Cancers

Learn how MSK specialists treat head and neck cancers using the most innovative approaches.

Doctor in green surgical scrubs wearing glasses and cap looking at camera.

Finding

Blood Will Tell: Scientists Find Clues to Immunotherapy Responders and Non-Responders

Why do some patients respond to immunotherapy while others do not? Blood may hold the answer.

photo of blood vials